ANDREW J. GRETHLEIN - 15 Aug 2023 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Operating Officer
Signature
/s/ Olivia Bloom for Andrew J. Grethlein
Issuer symbol
GERN
Transactions as of
15 Aug 2023
Net transactions value
$0
Form type
4
Filing time
21 Sep 2023, 20:32:12 UTC
Previous filing
24 Feb 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (right to buy) Award $0 +221,544 $0.000000 221,544 15 Aug 2023 Common Stock 221,544 $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.